Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a publicly traded Healthcare sector company. As of October 22, 2026, CRBP trades at $4.40 with a market cap of $85.49M and a P/E ratio of -0.91. CRBP moved +2.57% today. Year to date, CRBP is -45.55%; over the trailing twelve months it is -77.87%. Its 52-week range spans $4.22 to $20.56. Analyst consensus is strong buy with an average price target of $36.67. Rallies surfaces CRBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CRBP news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.40 |
| Market Cap | $85.49M |
| P/E Ratio | -0.91 |
| EPS | $-6.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.56 |
| 52-Week Low | $4.22 |
| Volume | 439 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.10M |
| Net Income | $-101.90M |
| Gross Margin | 0.00% |
7 analysts cover CRBP: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.67.